Problems Addressed by Jeeva Video eConsent

Waste of Research Investigator’s Time

A research investigator spends an average of 15-60 minutes per subject to obtain proper informed consent. The process is very repetitive.

Overload of Information for Patients in 15min

Patients are overwhelmed by the enormous amount of information they are expected to read and understand before they decide and provide informed consent in a single consultation. Patients can’t consume ~50 pages in 15 min.

Cost Associated with In-person Informed Consent

The direct and indirect costs of obtaining informed consent include investigator time, coordinators, nurses, and facilities.

Huge Logistical Burdens

Patients or caregivers and legally authorized representatives often have to travel in person to the investigation site and wait for several minutes to hours to complete and access proper informed consent.

Patient Comprehension

Investigators are required to verify that the patients or caregivers fully understand the risks and benefits of participating in a clinical trial before obtaining informed consent.

No Support for Various Scenarios

Modern clinical trials require flexible scenarios for obtaining informed consent in-person or remotely at multiple sites nationally or globally. There is a lack of flexible tools for all scenarios.

eCaaS Highlights - eConsent as a Service

eConsent as a Service Highlights

Jeeva remote eCaaS is an innovative SaaS-based collaboration platform hosted on the secure AWS cloud designed to assist clinical researchers. It facilitates the remote screening and recruitment of participants while ensuring full compliance with regulations by collecting accurate informed consent.

The eCaaS solution enables social media outreach to targeted groups, minimizes costly screen failures, and boosts success rates. It helps avoid information overload for patients and builds trust by organizing all trial information in one accessible central location, accelerating the recruitment process and timelines.
Request Demo

Advantages of Jeeva eConsent Solution

90% Savings in Researcher Time

The JeevaTM video eCaaS offers an impressive reduction in time for medical researchers and patients alike. Patients can learn about the trial leisurely from their homes.

Minimize Information Overload

Patients can consume information in multimedia formats at their convenience, all in one location at an online portal—the ability to refer back to the information at any time before and after signing the consent.

90% Cost Savings

A software subscription and support solution that fits your budget without compromising the compliance or integrity of the informed consent process.

Lower Logistic Burden

eCaaS reduces clinical investigators' logistical burden and time by 90+%. It eliminates having to repeat info to each patient, with video/multimedia formats for patients to consume on their own devices/schedules.

Informed Patients

Ensures patients have enough information with multimedia content and FAQs. Verify comprehension with a quiz or scored questionnaire.

Flexible Scenarios

Support is fully remote, entirely in-person, or hybrid, depending on participant preference, IRB requirements, or investigator comfort.

Compliance Programs Supported 

HIPAA
GCP
FDA
Eu General Data Protection Regulation
AICPA

Ditch the paper with Jeeva electronic in-person or remote video-based econsent –save time, cost, and stress

The Jeeva eConsent as a Service provides you with unlimited possibilities! Our eConsent module displays all the eConsent and eAssent forms associated with your study, enabling you to create, rename, edit, publish, assign, unpublish, or delete them.

You can view all the e-consents with details such as eConsent title, Participants assigned, Version number, Status, IRB approval date, IRB expiration date, and Site(s) for which the eConsent applies.

Request Demo
Handle Paper-based, Electronic In-person or Remote Touchless eConsent in One Place - eConsent as a Service
Variety of Scenarios - eConsent as a Service

Flexible Scenarios Supported by eConsent

  • The entirely in-person and paper-based informed consenting process was later scanned into electronic (PDF) format for archival and remote verification.
  • In-person electronic informed consent with eSignature by patients at an investigator site on an iPad during a visit.
  • Fully remote electronic informed consent via live interactive video call. Calls and eSignatures of the patient, investigator, and legally authorized representative are recorded.
  • Supports Central IRB or site-specific IRBs to review the eConsent experience as it would appear to the patients before they can approve for use.

Features of eCaaS Solution

  • Secure and compliant platform with the ability to configure for regulatory environments.
  • Legally binds customers, patients, and other stakeholders by electronic signatures.
  • Comprehensive patient experience.
  • Customizable and configurable.
  • Ability to configure for multiple languages.
  • Obtain proper electronic informed consent from patients without requiring in-person visits.
  • Easy to use for all stakeholders.
  • Accessible from various hardware devices of varying screen sizes.
Features of the Schedule - Schedule of Visits

Jeeva Video eConsent as a Service (eCaaS) is Backed by Study Support led by our CEO. 

eConsent as a Service

Jeeva Video eConsent as a Service (eCaaS) is Backed by Study Support led by our CEO. 

eConsent as a Service

Client Testimonials

Read all Testimonials

Client Testimonials

Jeeva is a game-changer for our rare diseases site/CRO. It is unfair to expect patients or healthy volunteers to visit a hospital or clinic when it is not necessary when a task can be effectively completed safely, remotely, and from the comfort of where they live.
Marshall Summar, MD, PhD, Director, Rare Disease Institute, Children's National Hospital
Marshall Summar, MD, Ph.DCEO, Uncommon Cures LLC
Jeeva platform & service is aligned with our vision to making CAR-T cell therapies affordable in emerging markets.
Rahul Purwar, Ph.D.
Rahul Purwar, Ph.D. Founder at ImmunoACT
Jeeva's simple and elegant video consenting solution saves me hundreds of hours of repetitive process of obtaining informed consent from study participants
Kimberly Chapman, MD, Ph.D.
Kimberly Chapman, MD, Ph.D.Principal Investigator, Childrens National Medical Center
Jeeva is backed by excellent customer service. We are enjoying our seamless transition to this platform for our longitudinal cohort study. Flexibility in programming.
Prof Lawrence Cheskin GMU
Lawrence Cheskin, MDProfessor and Chair, Nutrition and Food Studies, George Mason University
We are pleased to collaborate with Jeeva for the eCOA module for our investigator initiated observational study to understand toileting use by individuals with certain brain disorders
Dr. Terry Jo Bichell
Dr. Terry Jo BichellCombinedBrain
Very happy with the easy-to-use interface and the detailed user manual, which are supported by a highly responsive team! Jeeva's technology platform enables our patient concierge.
Nisha Venugopal, Ph.D.
Nisha Venugopal, Ph.D.Program Manager, IndoUS Organization for Rare Diseases
In looking for a software partner, our research coordinators and investigators in the field could call the Jeeva team anytime, get reliable support, and have reassurance as we enroll patients on the go. You can count on Jeeva when time is of the essence in operationalizing a clinical trial.
Dr. Emmanuel Gorospe
Dr. Emmanuel GorospeChief Medical Officer of Great Lakes Research Institute
There is an urgent need for validated tools to help ensure the continuity and integrity of clinical trial operations during and beyond the pandemic.
Frank Sasinowski, MPH, JD, Legendary Leader in Rare Diseases and Orphan Drugs Regulations
Frank Sasinowski, MPH, JDA legendary leader in Rare Diseases & Orphan Drugs Regulations
We are pleased to provide financial support - both in the form of a grant and an equity investment - to Jeeva. Jeeva is an excellent example of the kind of startup we look to support and pursuing an enormous market opportunity. We wish Dr. Rajasimha and his team the best of luck as they continue to build this company.
Sean Mallon
Sean MallonVice President, Virginia Innovation Partnership Corporation (VIPC)
Jeeva is a best-in-class solution for gathering clinical information with best-in-class customer service—two thumbs up.
David Hirsch, Founder, Special Father's Network, 21st Century Dads Foundation
David HirschFounder, Special Father's Network, 21st Century Dads Foundation
We are proud that Jeeva emerged as #1 on the National Science Foundation (NSF) Innovation-Corps Program leaderboard.
Josh Green, PMP George Mason University ICAP
Josh Green, PMPDirector ICAP, Small Business Development Center, George Mason University
Jeeva is a leader in the clinical trials software industry, with faster patient recruitment, focusing on global patient engagement.
Christiaan Engstrom Talencio Serious Talent Chats
Christiaan EngstromVice President, Talencio, Serious Talent Chats
We need to bring healthcare and product development costs down, especially in the developing world. Clinical trial costs are a significant part of product development costs. We are confident that by partnering with Jeeva, we can find the correct value-for-money proposition without compromising quality.
Shirish Arya
Shirish Arya Director of Strategy at ImmunoACT
Previous
Next
Read all Testimonials

Still Curious If Jeeva eCaaS is a Good Fit for Your Study?

Jeeva is designed to be disease-agnostic, device-agnostic, flexible, and modular to support patient-preferred decentralized or hybrid trial operations. Schedule a 30-minute call today to determine the fit. We will help you identify gaps in technology or protocol complexity to enable an informed decision.

Request Demo
Learn More
Jeeva Clinical Trials Inc.
10432 Balls Ford Rd Suite 300 Manassas, VA 20109
Make clinical trials efficient and accessible
Twitter Icon - Footer Linkedin Icon - Footer Youtube Icon - Footer Facebook Icon - Footer Instagram Icon - Footer

Solutions

Company

Quick Links